MICHAEL LEWIS to Everolimus
This is a "connection" page, showing publications MICHAEL LEWIS has written about Everolimus.
Connection Strength
0.275
-
MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694.
Score: 0.275